134 related articles for article (PubMed ID: 25748686)
1. Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.
Karachunskiy A; Roumiantseva J; Lagoiko S; Bührer C; Tallen G; Aleinikova O; Bydanov O; Korepanova N; Bajdun L; Nasedkina T; von Stackelberg A; Novichkova G; Maschan A; Litvinov D; Myakova N; Ponomareva N; Kondratchik K; Fechina L; Streneva O; Judina N; Scharapova G; Shamardina A; Gerbek I; Shapochnik A; Rumjanzew A; Henze G;
Leukemia; 2015 Sep; 29(9):1955-8. PubMed ID: 25748686
[No Abstract] [Full Text] [Related]
2. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
3. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
Yegin ZA; Aki S; Sucak G; Yagci M
Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
[No Abstract] [Full Text] [Related]
4. Trial initiated for liposomal vincristine in relapsed/refractory acute lymphoblastic leukemia.
Oncology (Williston Park); 2006 Sep; 20(10):1292. PubMed ID: 17024874
[No Abstract] [Full Text] [Related]
5. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
6. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
[No Abstract] [Full Text] [Related]
7. Steroids and risk of osteonecrosis in ALL: take a break.
van den Heuvel-Eibrink MM; Pieters R
Lancet Oncol; 2012 Sep; 13(9):855-7. PubMed ID: 22901621
[No Abstract] [Full Text] [Related]
8. Simplifying treatment for children with ALL.
Saha V
Lancet; 2007 Jan; 369(9556):82-3. PubMed ID: 17223452
[No Abstract] [Full Text] [Related]
9. Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85.
Schaison G; Olive D; Leverger G; Vannier JP; de Lumley L; Bancillon A; Cornu G
Haematol Blood Transfus; 1990; 33():467-72. PubMed ID: 2182438
[No Abstract] [Full Text] [Related]
10. A step forward in therapy for ALL in infants.
Ribera JM; Oriol A
Lancet; 2007 Jul; 370(9583):198-200. PubMed ID: 17658376
[No Abstract] [Full Text] [Related]
11. Severe hypertriglyceridemia in a 6-year-old boy with ALL relapse: successfully treated with plasmapheresis.
Winkler B; Kuhn S; Kunzmann S; Ruf K; Wiegering V; Schlegel PG
Klin Padiatr; 2013 Nov; 225(6):364-5. PubMed ID: 24158897
[No Abstract] [Full Text] [Related]
12. Fourth biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Hülsewede H; Bohlius J; Engert A
J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
[No Abstract] [Full Text] [Related]
13. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
Eiser C; Davies H; Jenney M; Stride C; Glaser A
Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
[TBL] [Abstract][Full Text] [Related]
14. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of dexamethasone before remission induction, in de novo childhood acute lymphoblastic leukemia.
López-Hernández MA; Alvarado M; De Diego J; Borbolla-Escoboza JR; Jiménez RM; Trueba E
Haematologica; 2004 Mar; 89(3):365-6. PubMed ID: 15020281
[TBL] [Abstract][Full Text] [Related]
16. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
[TBL] [Abstract][Full Text] [Related]
17. [Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
Rumiantseva IuV; Karachunskiĭ AI; Aleĭnikova OV; Fechina LG; Shamardina AV; Litvinov DV; Ponomareva NI; Boĭchenko EG; Dudkin SA; Streneva OV; Kondratchik KL; Mansurova EG; Minkina LM; Lapotentova ES; Iniushkina EV; Iudina NB; Pavlova GP; Zhukovskaia EV; Khlebnikova OP; Lagoĭko SN; Basharova EV; Denisov RE; Zlobina VD; Banshchikova ES; Aslanian KS; Kondakova EV; Tselousova EV; Miakova NV; Turobova TV; Ryskal' OV; Chipsanova NF; Varfolomeeva SR; Rumiantsev AG
Ter Arkh; 2010; 82(7):11-9. PubMed ID: 20853603
[TBL] [Abstract][Full Text] [Related]
18. Results and significance of six randomized trials in four consecutive ALL-BFM studies.
Riehm H; Gadner H; Henze G; Kornhuber B; Lampert F; Niethammer D; Reiter A; Schellong G
Haematol Blood Transfus; 1990; 33():439-50. PubMed ID: 2182435
[No Abstract] [Full Text] [Related]
19. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute lymphoblastic leukemia in children according to the Berlin-Frankfurt-Münster Program].
Rumiantsev AG; Samochatova EV; Tabet Khamdan
Pediatriia; 1991; (11):58-63. PubMed ID: 1766743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
